ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

J. Zhang

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2017: 1 paper

Papers 1

Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2174/1566524018666180308115705 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Z S Li · 1 shared paper, 2017 · strength 0.07
- Paper Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator… DOI 10.2174/1566524018666180308115705 ↗
Bin Yan Wu · 1 shared paper, 2017 · strength 0.07
- Paper Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator… DOI 10.2174/1566524018666180308115705 ↗
Zhengxiang Zhong · 1 shared paper, 2017 · strength 0.07
- Paper Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator… DOI 10.2174/1566524018666180308115705 ↗
Jun Gao · 1 shared paper, 2017 · strength 0.07
- Paper Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator… DOI 10.2174/1566524018666180308115705 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.